- ISIN
- US0231112063
- CUSIP
- 023111206
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Apr 1, 1993
Highlights
- Market Cap
- $6.63B
- Enterprise Value
- $6.50B
- EPS (TTM)
- -$0.15
- Total Revenue (TTM)
- $185.17M
- Gross Profit (TTM)
- $113.51M
- EBITDA (TTM)
- -$8.44M
- Year Range
- $12.96 - $20.90
- Target Price
- $2.17
- ROA (TTM)
- -5.21%
- ROE (TTM)
- -7.48%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
AMRN Performance Chart
Amarin Corporation plc (AMRN) is up 13.3% since the beginning of the year. At $16 per share, AMRN is trading 24.4% below its 52-week high of $21. Investors who bought $1,000 worth of AMRN shares 5 years ago would now be looking at an investment worth $174.
Loading charts...
Returns By Period
Amarin Corporation plc (AMRN) has returned 13.29% so far this year and 26.08% over the past 12 months. Over the last ten years, AMRN has returned -8.86% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
Amarin Corporation plc
- 1D
- -1.37%
- 1M
- 9.56%
- YTD
- 13.29%
- 6M
- 16.25%
- 1Y
- 26.08%
- 3Y*
- -11.49%
- 5Y*
- -29.50%
- 10Y*
- -8.86%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
AMRN Monthly Returns History
Based on dividend-adjusted daily data since Apr 5, 1993, AMRN's average daily return is +0.13%, while the average monthly return is +2.61%. At this rate, an investment would double in approximately 2.2 years.
Historically, 43% of months were positive and 57% were negative. The best month was Sep 2018 with a return of +414.9%, while the worst month was Jun 1998 at -75.3%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 7 months.
On a daily basis, AMRN closed higher 42% of trading days. The best single day was Sep 24, 2018 with a return of +314.7%, while the worst single day was Apr 25, 2007 at -79.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 6.92% | -7.51% | 4.78% | -3.67% | 4.02% | 9.11% | 13.29% | ||||||
| 2025 | 18.85% | -5.99% | -17.31% | 20.06% | 7.71% | 39.95% | -10.48% | 3.58% | 8.91% | -0.55% | -1.96% | -12.62% | 43.87% |
| 2024 | 29.89% | -5.31% | -16.75% | 3.38% | -6.07% | -20.46% | -0.87% | -8.28% | 0.22% | -7.53% | -12.02% | -4.90% | -44.25% |
| 2023 | 53.72% | 9.14% | -26.11% | -10.00% | -13.33% | 1.71% | 0.84% | -12.50% | -12.38% | -24.34% | 12.34% | 11.25% | -28.10% |
| 2022 | 7.42% | -8.56% | -0.60% | -18.24% | -46.10% | 2.76% | -10.74% | -11.28% | -7.63% | 12.84% | -6.50% | 5.22% | -64.09% |
| 2021 | 53.37% | -10.13% | -7.86% | -18.04% | -10.81% | -3.52% | -5.48% | 31.40% | -6.25% | -6.47% | -24.53% | -6.39% | -31.08% |
Benchmark Metrics
Amarin Corporation plc has an annualized alpha of 28.80%, beta of 0.63, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since April 05, 1993.
- This stock participated in 149.77% of S&P 500 Index downside but only 28.71% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.63 may look defensive, but with R2 of 0.01 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 28.80%
- Beta
- 0.63
- R²
- 0.01
- Upside Capture
- 28.71%
- Downside Capture
- 149.77%
Return for Risk
Risk / Return Rank
AMRN ranks 59 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Amarin Corporation plc (AMRN) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AMRN | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.53 | ||
| Sortino ratioReturn per unit of downside risk | -1.52 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 1.37 | -0.21 |
| Calmar ratioReturn relative to maximum drawdown | 0.79 | 2.78 | -2.00 |
| Martin ratioReturn relative to average drawdown | 1.19 | 12.44 | -11.25 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Amarin Corporation plc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Amarin Corporation plc was 99.97%, occurring on Mar 12, 2025. The portfolio has not yet recovered.
The current Amarin Corporation plc drawdown is 99.94%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 selloff2025 | -99.97%Mar 2025 | 31y 8mo | — | 32y 11moJul 1993 - now |
1993 correction1993 | -12.77%Jun 1993 | 1d | 15d | 16dJun 1993 - Jun 1993 |
1993 pullback1993 | -7.89%May 1993 | 8d | 2d | 10dMay 1993 - May 1993 |
1993 pullback1993 | -7.69%Apr 1993 | 0s | 6d | 6dApr 1993 - Apr 1993 |
1993 pullback1993 | -4.17%Jun 1993 | 0s | 2d | 2dJun 1993 - Jul 1993 |
Drawdown Indicators
| AMRN | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.97% | -56.78% | -43.19% |
Max Drawdown (1Y)Largest decline over 1 year | -33.33% | -9.10% | -24.23% |
Max Drawdown (3Y)Largest decline over 3 years | -72.02% | -18.90% | -53.12% |
Max Drawdown (5Y)Largest decline over 5 years | -93.15% | -25.43% | -67.72% |
Max Drawdown (10Y)Largest decline over 10 years | -98.34% | -33.92% | -64.42% |
Current DrawdownCurrent decline from peak | -99.94% | -1.80% | -98.14% |
Average DrawdownAverage peak-to-trough decline | -90.41% | -10.71% | -79.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.94% | 2.03% | +19.91% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Amarin Corporation plc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Amarin Corporation plc is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for AMRN relative to other companies in the Biotechnology industry. Currently, AMRN has a P/S ratio of 18.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for AMRN in comparison with other companies in the Biotechnology industry. Currently, AMRN has a P/B value of 14.7. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with AMRN
Add Amarin Corporation plc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with AMRN